[
  {
    "ts": null,
    "headline": "Insulet (PODD) Valuation: Is There More Room to Run After 22% YTD Gain?",
    "summary": "Insulet (PODD) shares are catching attention with a recent daily dip of 1.8%, despite gaining 22% for the year. Investors might be weighing the broader trends in the medical device space as they consider the company’s long-term growth trajectory. See our latest analysis for Insulet. Insulet’s share price has pulled back slightly from recent highs, but the company is still riding an impressive wave of momentum, with a year-to-date share price return over 22% and a standout total shareholder...",
    "url": "https://finnhub.io/api/news?id=7733deecb9546949df37142d40babd1cd674f06e21aede2258bf49c3329b6fc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760177345,
      "headline": "Insulet (PODD) Valuation: Is There More Room to Run After 22% YTD Gain?",
      "id": 137049499,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet (PODD) shares are catching attention with a recent daily dip of 1.8%, despite gaining 22% for the year. Investors might be weighing the broader trends in the medical device space as they consider the company’s long-term growth trajectory. See our latest analysis for Insulet. Insulet’s share price has pulled back slightly from recent highs, but the company is still riding an impressive wave of momentum, with a year-to-date share price return over 22% and a standout total shareholder...",
      "url": "https://finnhub.io/api/news?id=7733deecb9546949df37142d40babd1cd674f06e21aede2258bf49c3329b6fc0"
    }
  }
]